Carlos Juárez Crespo , Valentín Tascón Quevedo , Beatriz García Martínez , María Kislikova
{"title":"用于透析的血管通路","authors":"Carlos Juárez Crespo , Valentín Tascón Quevedo , Beatriz García Martínez , María Kislikova","doi":"10.1016/j.circv.2024.04.007","DOIUrl":null,"url":null,"abstract":"<div><p>Chronic kidney disease is a relatively frequent and evolutionary pathology, which in its final stage leads to renal replacement therapy. The most widely used is hemodialysis and to carry it out the patient must have adequate vascular access that allows a sufficient blood flow to be related to the hemodialysis machine. We usually talk about 2<!--> <!-->great options to achieve vascular access, the arteriovenous fístula (AVF) and the central venous catheter (CVC).</p><p>At present, it is known that the type of VA, both at the beginning and in the follow-up of hemodialysis, has a direct relationship with the mortality and morbidity of the patient.</p><p>All of this justifies the creation of multidisciplinary working groups to comprehensively address the management of VA in hemodialysis patients whose ultimate goal should be to achieve the highest possible incidence and prevalence of native vascular access.</p><p>Efficient coordination of these multidisciplinary groups has shown a decrease in the prevalence of catheters, highlighting the importance of a coordinating figure/s of these specialists.</p></div>","PeriodicalId":42671,"journal":{"name":"Cirugia Cardiovascular","volume":"31 4","pages":"Pages 175-182"},"PeriodicalIF":0.3000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1134009624000974/pdfft?md5=c885e22a598be0983fe50f42af6f6b35&pid=1-s2.0-S1134009624000974-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Accesos vasculares para diálisis\",\"authors\":\"Carlos Juárez Crespo , Valentín Tascón Quevedo , Beatriz García Martínez , María Kislikova\",\"doi\":\"10.1016/j.circv.2024.04.007\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Chronic kidney disease is a relatively frequent and evolutionary pathology, which in its final stage leads to renal replacement therapy. The most widely used is hemodialysis and to carry it out the patient must have adequate vascular access that allows a sufficient blood flow to be related to the hemodialysis machine. We usually talk about 2<!--> <!-->great options to achieve vascular access, the arteriovenous fístula (AVF) and the central venous catheter (CVC).</p><p>At present, it is known that the type of VA, both at the beginning and in the follow-up of hemodialysis, has a direct relationship with the mortality and morbidity of the patient.</p><p>All of this justifies the creation of multidisciplinary working groups to comprehensively address the management of VA in hemodialysis patients whose ultimate goal should be to achieve the highest possible incidence and prevalence of native vascular access.</p><p>Efficient coordination of these multidisciplinary groups has shown a decrease in the prevalence of catheters, highlighting the importance of a coordinating figure/s of these specialists.</p></div>\",\"PeriodicalId\":42671,\"journal\":{\"name\":\"Cirugia Cardiovascular\",\"volume\":\"31 4\",\"pages\":\"Pages 175-182\"},\"PeriodicalIF\":0.3000,\"publicationDate\":\"2024-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S1134009624000974/pdfft?md5=c885e22a598be0983fe50f42af6f6b35&pid=1-s2.0-S1134009624000974-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cirugia Cardiovascular\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1134009624000974\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"SURGERY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cirugia Cardiovascular","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1134009624000974","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"SURGERY","Score":null,"Total":0}
Chronic kidney disease is a relatively frequent and evolutionary pathology, which in its final stage leads to renal replacement therapy. The most widely used is hemodialysis and to carry it out the patient must have adequate vascular access that allows a sufficient blood flow to be related to the hemodialysis machine. We usually talk about 2 great options to achieve vascular access, the arteriovenous fístula (AVF) and the central venous catheter (CVC).
At present, it is known that the type of VA, both at the beginning and in the follow-up of hemodialysis, has a direct relationship with the mortality and morbidity of the patient.
All of this justifies the creation of multidisciplinary working groups to comprehensively address the management of VA in hemodialysis patients whose ultimate goal should be to achieve the highest possible incidence and prevalence of native vascular access.
Efficient coordination of these multidisciplinary groups has shown a decrease in the prevalence of catheters, highlighting the importance of a coordinating figure/s of these specialists.